An investigational product is a pharmaceutical, biologic, or medical device being evaluated in a clinical trial, including active comparators, placebo, or combination products. It is identified in trial protocols, pharmacy manuals, labels, and accountability records to ensure proper handling, documented storage, blinding, and administration to study subjects throughout the clinical investigation, from site receipt to final product return or destruction.
Investigational product terminology appears in clinical trial protocols, pharmacy manuals, blinded labels, accountability logs, and investigator brochures. Translators must maintain the distinction between investigational product and marketed product, and preserve blinded label formats, specific dosing instructions, and critical storage handling text without revealing randomized treatment assignment or unblinding study participants.
A common error is translating “investigational product” as “investigative product” or “research tool,” which weakens its regulatory status as a clinical trial treatment. Inaccurate labels, pharmacy manuals, or accountability records can blur that status or potentially unblind the study if treatment wording is inconsistent across languages, versions, or source documents.
FDA, CE/MDR and NMPA reviewers assess the submitted wording itself. Regulatory bodies require traceable, accountable translation, and an inconsistent term can delay or fail a submission.
Angel Translation locks terms like this into a project terminology base before expert review begins, so the same source term resolves to the same target term across every document in a submission — and stays consistent in the next revision. See the 8-step AI + expert workflow.
Send us the files. Acknowledged in 4 hours, quoted in 24.
Request a Quote →Life Science solutions →